Compare Shell PLC (SHEL) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs Summit Therapeutics Inc — how do they compare? Shell PLC trades at $86.69 (market cap $235.24B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Shell PLC is far larger — about 22.4× Summit Therapeutics Inc's market cap, and Shell PLC pays a 3.63% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SHEL | SMMT | |
|---|---|---|
Market Cap | $235.24B | $10.48B |
Sector | Energy | Health |
52-Week High | $94.15 | $29.32 |
52-Week Low | $70.31 | $13.05 |
Enterprise Value | $287.77B | $9.90B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
